Literature DB >> 20040873

Glaucoma in Latinos/Hispanics.

Elma Kim1, Rohit Varma.   

Abstract

PURPOSE OF REVIEW: Large differences exist in the prevalence of glaucoma among different racial and ethnic groups. The purpose of this article is to review the findings of the Los Angeles Latino Eye Study (LALES) with respect to the prevalence of glaucoma in Latinos and to identify factors associated with the development of glaucoma in this population. RECENT
FINDINGS: LALES is the largest prevalence survey of eye disease in Latinos of Mexican origin to date. This review discusses the findings of LALES, including data that demonstrate specific risk factors and manifestations of open-angle glaucoma in this rapidly growing population.
SUMMARY: The LALES data on ocular disease among Latinos of Mexican ancestry have crucial implications for effective clinical and public-health interventions. Understanding the particular characteristics of glaucoma in the Latino population is essential for correct diagnosis and management of this potentially blinding condition.

Entities:  

Mesh:

Year:  2010        PMID: 20040873     DOI: 10.1097/ICU.0b013e3283360b1e

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  6 in total

1.  Factors associated with vision loss in Black or Hispanic patients 1 year after standalone or combined Ahmed glaucoma valve surgery.

Authors:  Nicholas E Tan; Shannon X Chen; Nathan M Radcliffe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-08-26       Impact factor: 3.535

2.  Improving Access to Eye Care among Persons at High-Risk of Glaucoma in Philadelphia--Design and Methodology: The Philadelphia Glaucoma Detection and Treatment Project.

Authors:  Lisa Hark; Michael Waisbourd; Jonathan S Myers; Jeffrey Henderer; John E Crews; Jinan B Saaddine; Jeanne Molineaux; Deiana Johnson; Harjeet Sembhi; Shayla Stratford; Ayman Suleiman; Laura Pizzi; George L Spaeth; L Jay Katz
Journal:  Ophthalmic Epidemiol       Date:  2016-03-07       Impact factor: 1.648

3.  Association of OPA1 polymorphisms with NTG and HTG: a meta-analysis.

Authors:  Yatu Guo; Xia Chen; Hongtuan Zhang; Ningdong Li; Xiong Yang; Wenbo Cheng; Kanxing Zhao
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

4.  Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.

Authors:  Alfonso García-López; José A Paczka; Jesús Jiménez-Román; Curt Hartleben
Journal:  BMC Ophthalmol       Date:  2014-12-19       Impact factor: 2.209

5.  A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle Glaucoma.

Authors:  Francisco Gómez-Aguayo; José A Paczka; Rubén Leñero-Córdova; Jesús Jiménez-Román; Jaime Davila-Villarreal; Curt Hartleben; Leopoldo Baiza-Durán; Oscar Olvera-Montaño; Francisco García-Velez; Patricia Muñoz-Villegas
Journal:  Ophthalmol Ther       Date:  2018-04-21

6.  Homocysteine induces oxidative stress to damage trabecular meshwork cells.

Authors:  Zhi-Peng You; Yue-Zhi Zhang; Yu-Lan Zhang; Lu Shi; Ke Shi
Journal:  Exp Ther Med       Date:  2018-03-19       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.